Skip to content

Study on reference range of pregnancy-specific TSH, FT3 and FT4 in Guangxi

Study on reference range of pregnancy-specific TSH, FT3 and FT4 in Guangxi

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040365
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid related diseases

Interventions

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Thyroid peroxidase antibody (TPOAb), thyroid globulin antibody (TgAb) negative (immunochemiluminescence and other sensitive determination methods); (2) No personal or family history of thyroid disease; (3) An invisible or palpable goiter; (4) Those who do not take drugs (except estrogen); (5) Adequate iodine nutrition

Exclusion criteria

Exclusion criteria: (1) Multiple pregnancy; (2) Hyperemesis gravidarum; (3) Those with pregnancy complications (including gestational diabetes mellitus, gestational hypertension disease, anemia, etc.) or adverse pregnancy outcomes (including abortion, premature delivery, premature rupture of membranes, placental dissection, delivery of low birth weight children, etc.); (4) Those with a history of adverse pregnancy (including recurrent abortion, stillbirth, and neonatal death); (5) Patients with severe internal and surgical diseases such as diabetes, hypertension, anemia, tumor, liver and kidney diseases; (6) Patients with autoimmune diseases, such as systemic lupus erythematosus; (7) Previous history of hypothalamic-pituitary disease.

Design outcomes

Primary

MeasureTime frame
Thyroid stimulating hormone;FT3;FT4;Thyroid peroxidase antibody;Anti thyroglobulin antibody;

Countries

China

Contacts

Public ContactQin Yingfen

The First Affiliated Hospital of Guangxi Medical University

yingfenq@126.com+86 13607862619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026